-
1
-
-
0033832154
-
5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours
-
Chandy T, Das GS, Rao GHR (2000) 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul 17: 625-638.
-
(2000)
J Microencapsul
, vol.17
, pp. 625-638
-
-
Chandy, T.1
Das, G.S.2
Rao, G.H.R.3
-
2
-
-
0035668828
-
In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres
-
Chiang CH, Tung SM, Lu Dw, Yeh MK (2001) In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres. J Ocular Pharmacol Thera 17: 545-553.
-
(2001)
J Ocular Pharmacol Thera
, vol.17
, pp. 545-553
-
-
Chiang, C.H.1
Tung, S.M.2
Lu, D.W.3
Yeh, M.K.4
-
3
-
-
0032831579
-
5-Fluorouracil loaded chitosan microspheres for chemoembolization
-
Denkbas EB, Seyyal M, Piskin E (1999) 5-Fluorouracil loaded chitosan microspheres for chemoembolization. J Microencapsul 16: 741-749.
-
(1999)
J Microencapsul
, vol.16
, pp. 741-749
-
-
Denkbas, E.B.1
Seyyal, M.2
Piskin, E.3
-
4
-
-
0034863372
-
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro
-
El Maghraby GM, Williams AC, Barry BW (2001) Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol 53: 1069-1077.
-
(2001)
J Pharm Pharmacol
, vol.53
, pp. 1069-1077
-
-
El Maghraby, G.M.1
Williams, A.C.2
Barry, B.W.3
-
5
-
-
0024330631
-
Quantitative evaluation of targeted drug delivery systems
-
Gupta PK, Hung CT (1989) Quantitative evaluation of targeted drug delivery systems. Int J Pharm 56: 217-226.
-
(1989)
Int J Pharm
, vol.56
, pp. 217-226
-
-
Gupta, P.K.1
Hung, C.T.2
-
6
-
-
0031215752
-
The inhibitory effect of tissue plasminogen activator combined with 5-fluorouracil polyphase liposome on the scar formation in experimental filtration surgery
-
Jing M, Xi S, Chen R (1997) The inhibitory effect of tissue plasminogen activator combined with 5-fluorouracil polyphase liposome on the scar formation in experimental filtration surgery. Zhonghua Yan Ke Za Zhi 33: 376-380.
-
(1997)
Zhonghua Yan Ke Za Zhi
, vol.33
, pp. 376-380
-
-
Jing, M.1
Xi, S.2
Chen, R.3
-
7
-
-
0023992081
-
Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy
-
Joondeph BC, Peyman GA, Khoobehi B, Yue BY (1988) Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy. Ophthalmic Surg 19: 252-256.
-
(1988)
Ophthalmic Surg
, vol.19
, pp. 252-256
-
-
Joondeph, B.C.1
Peyman, G.A.2
Khoobehi, B.3
Yue, B.Y.4
-
8
-
-
0031905169
-
Gelatine nanoencapsulation of protein/peptide drugs using an emulsifier-free emulsion method
-
Li JK, Wang N, Wu XS (1998) Gelatine nanoencapsulation of protein/ peptide drugs using an emulsifier-free emulsion method. J Microencapsul 15: 163-172.
-
(1998)
J Microencapsul
, vol.15
, pp. 163-172
-
-
Li, J.K.1
Wang, N.2
Wu, X.S.3
-
9
-
-
0034531262
-
Sustained release of 5-fluorouracil from polymeric nanoparticles
-
McCarron PA, Woolfson AD, Keating SM (2000) Sustained release of 5-fluorouracil from polymeric nanoparticles. J Pharm Pharmacol 52: 1451-1459.
-
(2000)
J Pharm Pharmacol
, vol.52
, pp. 1451-1459
-
-
McCarron, P.A.1
Woolfson, A.D.2
Keating, S.M.3
-
10
-
-
0024541502
-
Preparation and evaluation of polyglutaradehyde nanoparticles containing 5-fluorouracil
-
Mukherji G, Murthy RSR, Miglani BD (1989) Preparation and evaluation of polyglutaradehyde nanoparticles containing 5-fluorouracil. Int J Pharm 50: 15-19.
-
(1989)
Int J Pharm
, vol.50
, pp. 15-19
-
-
Mukherji, G.1
Murthy, R.S.R.2
Miglani, B.D.3
-
11
-
-
0025244272
-
Preparation and evaluation of cellose nanospheres containing 5-fluorouracil
-
Mukherji G, Murthy RSR, Miglani BD (1990) Preparation and evaluation of cellose nanospheres containing 5-fluorouracil. Int J Pharm 65: 1-5.
-
(1990)
Int J Pharm
, vol.65
, pp. 1-5
-
-
Mukherji, G.1
Murthy, R.S.R.2
Miglani, B.D.3
-
12
-
-
0029877192
-
Macromolecular prodrugs of 5-fluorouracil. 2: Enzymatic degradation
-
Nichifor M, Schacht EH, Seymour LW (1996) Macromolecular prodrugs of 5-fluorouracil. 2: Enzymatic degradation. J Control Release 39: 79-92.
-
(1996)
J Control Release
, vol.39
, pp. 79-92
-
-
Nichifor, M.1
Schacht, E.H.2
Seymour, L.W.3
-
14
-
-
0032095665
-
Design of macromolecular prodrug of 5-fluorouracil using N-acetylpolygalactosamine as a targeting carrier to hepatoma
-
Ouchi T, Tada M, Matsumoto M, Ohya Y, Hasegawa K, Arai Y, Kadowaki K, Akao S, Matsumoto T, Suzuki S, Suzuki M (1998) Design of macromolecular prodrug of 5-fluorouracil using N-acetylpolygalactosamine as a targeting carrier to hepatoma. React Funct Polym 37: 235-244.
-
(1998)
React Funct Polym
, vol.37
, pp. 235-244
-
-
Ouchi, T.1
Tada, M.2
Matsumoto, M.3
Ohya, Y.4
Hasegawa, K.5
Arai, Y.6
Kadowaki, K.7
Akao, S.8
Matsumoto, T.9
Suzuki, S.10
Suzuki, M.11
-
15
-
-
0037231492
-
Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma
-
Roullin VG, Lemaire L, Venier-Julienne MC, Faisant N, Franconi F, Benoit JP (2003) Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma. Anticancer Res 23: 21-25.
-
(2003)
Anticancer Res
, vol.23
, pp. 21-25
-
-
Roullin, V.G.1
Lemaire, L.2
Venier-Julienne, M.C.3
Faisant, N.4
Franconi, F.5
Benoit, J.P.6
-
16
-
-
0017568870
-
Drug-carrier property of albumin microspheres in chemo-therapy I. Tissue distribution of microsphere-entrapped 5-fluorouracil in mice
-
Sugibagashi K, Morimoto Y, Nadai T, Kato Y (1997) Drug-carrier property of albumin microspheres in chemo-therapy I. Tissue distribution of microsphere-entrapped 5-fluorouracil in mice. Chem Pharm Bull 25: 3433-3438.
-
(1997)
Chem Pharm Bull
, vol.25
, pp. 3433-3438
-
-
Sugibagashi, K.1
Morimoto, Y.2
Nadai, T.3
Kato, Y.4
|